Non-Hodgkin Lymphoma (NHL)

In order for our site to display correctly you will need a newer version of your web browser.

Currently we test and support the following browsers:

FireFox version 3.0 and above (Windows and Mac)
Safari version 5.0 and above (Windows and Mac)
Internet Explorer version 7.0 and above (Windows)

Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.

Research

Disease Information

Disease Information

Leukemias / Lymphomas: Non-Hodgkin Lymphoma (NHL)

Alternate Names: NHL

Definition

Non-Hodgkin lymphomas (NHL) are tumors of the peripheral lymph nodes, thymus or abdominal organs, such as the bowel, but can appear in other sites. These tumors differ substantially from lymphomas seen in adults. In children, NHL may behave similarly to acute leukemia in that both cancers can involve bone marrow, blood, skin and the central nervous system.

Incidence

Lymphomas are the third most common malignant disease of children, after acute leukemia and brain tumors.
Fifty-five percent of childhood lymphomas are non-Hodgkin lymphomas.
Approximately nine in one million children under age 15 will develop non-Hodgkin lymphoma each year.

Influencing Factors

Children with immunodeficiencies have a greatly increased risk of developing non-Hodgkin lymphoma.

Survival Rates

Approximately 80 percent of patients with non-Hodgkin lymphoma can be cured with treatment.
Children with early, localized stages of the disease have about a 90 percent chance of cure.

Treatment Strategies

Therapy varies depending on subtypes and stages of non-Hodgkin lymphoma. Chemotherapy, using a combination of drugs, has proven effective. Because of the effectiveness of chemotherapy, there is little role for radiation treatment.

Current Research

Researchers are looking for better ways to refine treatment for lymphoma according to the extent of the disease and the tissue subtype.
Specific therapies are being developed to target against cell surface antigens expressed by lymphoma cells or their molecular lesions.
Molecular studies are being conducted to search for the mechanisms of the development of lymphoma.

The St. Jude Web site is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through this site should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.

Print Email This Article